Similar articles for PMID: 26658271

Year	Number of Results
1999	2
2000	6
2002	1
2003	2
2004	3
2005	4
2006	3
2007	4
2008	4
2009	5
2010	5
2011	6
2012	4
2013	5
2014	6
2015	11
2016	3
2017	6
2018	8
2019	6
2020	6
2021	5
2022	1
2023	3
2024	0

1

Aptamers Binding to c-Met Inhibiting Tumor Cell Migration.

Piater B, Doerner A, Guenther R, Kolmar H, Hock B. Piater B, et al. PLoS One. 2015 Dec 11;10(12):e0142412. doi: 10.1371/journal.pone.0142412. eCollection 2015. PLoS One. 2015. PMID: 26658271 Free PMC article.

2

A DNA aptamer to c-Met inhibits cancer cell migration.

Ueki R, Sando S. Ueki R, et al. Chem Commun (Camb). 2014 Nov 7;50(86):13131-4. doi: 10.1039/c4cc06016d. Chem Commun (Camb). 2014. PMID: 25223895

3

Anti-c-MET Nanobody - a new potential drug in multiple myeloma treatment.

Slørdahl TS, Denayer T, Moen SH, Standal T, Børset M, Ververken C, Rø TB. Slørdahl TS, et al. Eur J Haematol. 2013 Nov;91(5):399-410. doi: 10.1111/ejh.12185. Epub 2013 Sep 16. Eur J Haematol. 2013. PMID: 23952536

4

Targeting c-met receptor tyrosine kinase by the DNA aptamer SL1 as a potential novel therapeutic option for myeloma.

Zhang Y, Gao H, Zhou W, Sun S, Zeng Y, Zhang H, Liang L, Xiao X, Song J, Ye M, Yang Y, Zhao J, Wang Z, Liu J. Zhang Y, et al. J Cell Mol Med. 2018 Dec;22(12):5978-5990. doi: 10.1111/jcmm.13870. Epub 2018 Oct 24. J Cell Mol Med. 2018. PMID: 30353654 Free PMC article.

5

Molecular Epitope Determination of Aptamer Complexes of the Multidomain Protein C-Met by Proteolytic Affinity-Mass Spectrometry.

Lupu L, Wiegand P, Hüttmann N, Rawer S, Kleinekofort W, Shugureva I, Kichkailo AS, Tomilin FN, Lazarev A, Berezovski MV, Przybylski M. Lupu L, et al. ChemMedChem. 2020 Feb 17;15(4):363-369. doi: 10.1002/cmdc.201900489. Epub 2020 Jan 16. ChemMedChem. 2020. PMID: 31825565

6

Transcriptional activation of the hepatocyte growth factor receptor (c-met) gene by its ligand (hepatocyte growth factor) is mediated through AP-1.

Seol DW, Chen Q, Zarnegar R. Seol DW, et al. Oncogene. 2000 Feb 24;19(9):1132-7. doi: 10.1038/sj.onc.1203404. Oncogene. 2000. PMID: 10713700

7

Ovarian cancer ascites enhance the migration of patient-derived peritoneal mesothelial cells via cMet pathway through HGF-dependent and -independent mechanisms.

Matte I, Lane D, Laplante C, Garde-Granger P, Rancourt C, Piché A. Matte I, et al. Int J Cancer. 2015 Jul 15;137(2):289-98. doi: 10.1002/ijc.29385. Epub 2014 Dec 18. Int J Cancer. 2015. PMID: 25482018 Free article.

8

Fully human monoclonal antibodies to hepatocyte growth factor with therapeutic potential against hepatocyte growth factor/c-Met-dependent human tumors.

Burgess T, Coxon A, Meyer S, Sun J, Rex K, Tsuruda T, Chen Q, Ho SY, Li L, Kaufman S, McDorman K, Cattley RC, Sun J, Elliott G, Zhang K, Feng X, Jia XC, Green L, Radinsky R, Kendall R. Burgess T, et al. Cancer Res. 2006 Feb 1;66(3):1721-9. doi: 10.1158/0008-5472.CAN-05-3329. Cancer Res. 2006. PMID: 16452232

9

Noncompetitive inhibition of hepatocyte growth factor-dependent Met signaling by a phage-derived peptide.

Tam EM, Runyon ST, Santell L, Quan C, Yao X, Kirchhofer D, Skelton NJ, Lazarus RA. Tam EM, et al. J Mol Biol. 2009 Jan 9;385(1):79-90. doi: 10.1016/j.jmb.2008.09.091. Epub 2008 Oct 15. J Mol Biol. 2009. PMID: 18973760

10

Quercetin inhibits HGF/c-Met signaling and HGF-stimulated melanoma cell migration and invasion.

Cao HH, Cheng CY, Su T, Fu XQ, Guo H, Li T, Tse AK, Kwan HY, Yu H, Yu ZL. Cao HH, et al. Mol Cancer. 2015 May 14;14:103. doi: 10.1186/s12943-015-0367-4. Mol Cancer. 2015. PMID: 25971889 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

104 results

Results by year